New cell therapy aims to fight leukemia relapse after transplant
NCT ID NCT03068819
Summary
This study tested a new treatment for children and adults whose acute myeloid leukemia (AML) returned after a stem cell transplant. Researchers combined a standard donor cell infusion with a special type of donor immune cell, called a 'memory-like' natural killer (NK) cell. The goal was to see if this combination was safe and could better fight the leukemia and keep it from coming back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.